Private Label vs White Label Peptides: What the Difference Actually Costs You
The terms “private label” and “white label” get used interchangeably across the peptide market and they shouldn’t be. The two models have different cost curves, different IP postures, different lead times, and different risk surfaces. Picking the wrong one costs brands a quarter at minimum and a competitive position at worst.
Here is the precise version, and where each model actually fits.
The actual definitions
White label is a stocked, finished product in the manufacturer’s standard packaging that you re-label and resell under your brand. The formulation is the manufacturer’s. The packaging is the manufacturer’s. You apply your label, your insert, and (sometimes) your secondary packaging. The product is functionally identical to whatever the same manufacturer is shipping to your competitors who also chose the white-label path.
Private label is a manufactured run in your label, your packaging, and (optionally) your formulation. The formulation may still be the manufacturer’s catalog formulation, but the packaging is yours and the SKU is yours. Custom-formulation private label takes it a step further: the formulation itself is developed for your brand and (depending on the IP arrangement) owned by your brand.
The shorthand: white label is a shelf product you re-label. Private label is a manufacturing relationship.
How they differ on lead time
White-label lead times are short because the product is stocked. You confirm artwork, the manufacturer applies your label, you ship. Two to four weeks, often less.
Private-label lead times are longer because the product is being manufactured for you. Cataloged formulation in standard packaging: 4–6 weeks first run, 7–14 days re-order. Cataloged formulation in custom packaging: 8–12 weeks first run. Custom formulation in custom packaging: 12–20 weeks first run.
The lead-time gap is the price you pay for differentiation. Brands launching tomorrow pick white label. Brands building for year three pick private label.
How they differ on margin
White-label per-unit cost is usually slightly higher than private-label per-unit cost at comparable volumes, because the manufacturer is recovering the inventory carrying cost on the stocked finished good.
Private-label per-unit cost is lower at scale, but adds a one-time setup cost (artwork, packaging tooling on custom packaging, formulation development on custom formulation). The break-even between white label and private label, in our experience, is somewhere around 3,000–5,000 units of cumulative volume on the same SKU. Below that, white label often wins on total cost. Above it, private label dominates.
How they differ on IP
White-label IP is the manufacturer’s. Your competitors who buy from the same manufacturer are selling functionally identical product. Your moat is brand, marketing, and distribution — not formulation.
Private-label IP varies. On a cataloged formulation, the formulation is still the manufacturer’s; you have a brand and packaging moat. On a custom formulation, the IP arrangement is part of the master services agreement. Most brands negotiate ownership of brand-specific custom formulations they fund the development of, with the manufacturer retaining underlying methods.
If your competitive thesis depends on a differentiated formulation, you need private label with a custom formulation. If your competitive thesis depends on brand and distribution, white label or cataloged private label is enough.
How they differ on risk
White-label risk is concentrated on the manufacturer side. If the manufacturer has a quality event, every brand using their stocked finished good is exposed simultaneously. The single benefit: when something goes wrong, the response is fast because everyone is dealing with the same lot.
Private-label risk is more isolated. Your lot is your lot; a quality event at the manufacturer is investigated against your specific production run. The trade-off: your brand carries the response, your customer-facing communications are yours to draft, and your liability surface is, in practice, larger.
Which one fits your stage
A working framework:
- Pre-launch validation. White label. You are still figuring out whether the SKU sells. Don’t spend custom packaging dollars on a hypothesis.
- First 6–12 months of demand. Cataloged private label, standard packaging. Brand differentiation on the label without custom packaging tooling cost.
- Validated SKU, scaling demand. Cataloged private label, custom packaging. Retail-quality differentiation, longer lead time, better unit economics at volume.
- Differentiated brand, scale operation. Custom-formulation private label. Real moat, real lead time, real MSA. The category leaders all live here.
Most brands move through these stages in order. The mistake is jumping to stage 4 before stage 1 has paid for itself.
What this means for sourcing
Pick a manufacturing partner who can support both models — not just one. The brand that starts on white label and never plans to graduate is the brand that gets stuck. The brand that starts on custom-formulation private label without validating the SKU is the brand that burns through its first round on inventory that doesn’t sell.
The right partner can run you on white label this quarter and on cataloged private label next quarter without forcing a supplier change. Read more in our 10-point checklist for choosing a private-label peptide manufacturer.